Search

This report examines a small but key aspect of Channeling — the costs of operating the demonstration itself. The ten sites incurred costs of $23 million as they prepared for and later provided case management and long-term care services to clients between September 1980 and June 1984. In addition to the project costs, the states spent $2.8 milli

This project expands ASPE's Medicare post-acute care (PAC) episode analytic file in terms of sample size and the number of years used (2006-2008) to provide more detailed characteristics of PAC episodes under different definitions. This analysis provides information on changes in PAC use, allows for more detailed understanding of the patterns of

This preliminary report addresses a number of issues pertaining to the development of a combined research and clinical instrument for assessing the functional status of clients in the National Long-Term Care Channeling Demonstration. The report contains an extensive literature review, evaluation of existing instruments and appraisal of the experie

The report contains the results of actuarial and policy analyses of the CLASS Act and the legal analysis of various benefit plan options. This report contains important findings that will help advance the cause of charting a path to affordable and sustainable long-term care options. [48 PDF pages]

The Technical Review Panel on the Medicare Trustees Report was established by the Department of Health and Human Services in 2016 to review the assumptions and methods underlying the Medicare Trust Funds (Hospital Insurance and Supplementary Medical Insurance) annual reports to Congress. The Panel, which has nine members, reviewed the Medicare a

U.S. Department of Health and Human Services Analysis of Channeling Project Costs Craig Thornton, Joanna Will and Mark Davies Mathematica Policy Research, Inc. March 1985, Revised May 1986 PDF Version: http://aspe.hhs.gov/daltcp/reports/1986/projcost.pdf (107 PDF pages)

This report analyzed data on all pediatric hospitalizations of $25,000 or more in California to determine the relationship between source of payment and various characteristics, including age and diagnosis. [39 PDF pages]

The goals of this study were to make the MDS compliant with CHI-endorsed content and messaging standards, and to produce a policy relevant report that describes the issues with integrating these HIT standards into federally-required patient assessment applications. This report summarizes the complete findings and recommendations of this study. [48

IGIV is a plasma product that is used to treat patients with immune system disorders. A significant percentage of IGIV use is for off-label indications. Current conditions in the IGIV industry and market are complex and rapidly evolving. The growing demand for IGIV, supply capacity issues, changes in reimbursement, and the relocation of sites of s